Genomic Vision

Genomic Vision EBITDA per Employee

The EBITDA per Employee of Genomic Vision (GV.PA) as of Oct 23, 2026 is -222,115.38 EUR. In the previous year, EBITDA per Employee was -171,269.23 EUR — a change of 29.69% (lower).

EBITDA per Employee

-222,115.38EUR

YoY

29.69%

Last updated:

EBITDA per Employee of Genomic Vision is 2022 -222,115.38 EUR. EBITDA per Employee of Genomic Vision was 2021 -171,269.23 EUR. It decreases by 29.69% lower compared to the previous year.

The Genomic Vision EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2015
-155,346.15 EUR
Jan 1, 2016
-314,192.31 EUR
Jan 1, 2017
-302,769.23 EUR
Jan 1, 2018
-225,538.46 EUR
Jan 1, 2019
-161,692.31 EUR
Jan 1, 2020
-168,846.15 EUR
Jan 1, 2021
-171,269.23 EUR
Jan 1, 2022
-222,115.38 EUR
The Genomic Vision EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-222,115.38EUR+29.69%
-171,269.23EUR+1.44%
-168,846.15EUR+4.42%
-161,692.31EUR-28.31%
-225,538.46EUR-25.51%
-302,769.23EUR-3.64%
-314,192.31EUR+102.25%
-155,346.15EUR+101.95%
-76,923.08EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genomic Vision Stock analysis

What does Genomic Vision do? Genomic Vision is a biotechnology company that was founded in 2004. It is based in Bagneux, France, and develops and markets innovative molecular diagnostic tools and services based on its patented platform technology. The company's business model is based on collaboration with large pharmaceutical and diagnostic companies to help accelerate their product development and improve their clinical outcomes. Genomic Vision specializes in genetic diagnostics and offers a platform for analyzing DNA structures, allowing for the detection and quantification of genetic changes associated with various diseases such as cancer, neurological disorders, and rare diseases. The company also offers customized solutions and services tailored to the specific needs of its customers. In addition, Genomic Vision licenses its technology and patents to pharmaceutical companies and other organizations. The company has already partnered with Hitachi High-Technologies in Japan to market its platform for cancer monitoring and to develop molecular tests for cancer and other diseases. Genomic Vision has also introduced products such as the FiberVision system for visualizing and analyzing DNA fibers and is working on a new diagnostic test for precise diagnosis of autism and other neurological disorders. The company aims to improve the diagnosis of genetic diseases and advance genomic research. With its patented technology and expertise in molecular diagnostics, Genomic Vision is well positioned to drive the development of new and innovative products. Overall, Genomic Vision is an emerging company focused on the development of molecular diagnostic tools and services, and has a solid foundation in DNA visualization and analysis. With its innovative products and services, the company is well positioned to drive the growth of the molecular diagnostics market and establish itself as a key player in the field. Genomic Vision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomic Vision stock

EBITDA per Employee of Genomic Vision is -222,115.38 EUR in 2022.

EBITDA per Employee of Genomic Vision changed from -171,269.23 EUR to -222,115.38 EUR, representing a 29.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Genomic Vision since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Genomic Vision historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Genomic Vision

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Genomic Vision